CMS proposing to cut payments for new Part B drugs

In a proposed rule released Thursday, CMS said it plans to cut Medicare Part B reimbursement for the first six months after new drugs are launched. Instead of paying providers the wholesale acquisition cost (WAC) plus a 6%

Read the full 386 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE